Medical Condition News

RSS

New, effective and less toxic therapeutic option for patients with HER2-positive breast cancer

Patients with HER2-positive breast cancer, a particularly aggressive form of breast cancer, now have a new, effective and less toxic therapeutic option.

24 Feb 2013

LINX magnetic device safe and effective in treating gastroesophageal reflux disease

A study published February 21st in the New England Journal of Medicine (NEJM) provides clinical evidence of the safety and effectiveness of a new magnetic medical device to treat gastroesophageal reflux disease (GERD).

24 Feb 2013

New data from Boehringer Ingelheim's tiotropium Respimat Phase III UniTinA-asthma programme

Tiotropium delivered once daily via Respimat significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic despite treatment with at least ICS/LABA, irrespective of their allergic status.

24 Feb 2013

Clearview announces arrival of Catalys Precision Laser System in Southern CA

Clearview Eye & Laser Medical Center announces the arrival of the world's most sophisticated laser cataract surgery system in Southern CA.

24 Feb 2013

UAB becomes first in America to test experimental therapy for emphysema

A patient at the University of Alabama at Birmingham (UAB) became the first person in America to undergo an investigational therapy for emphysema that uses a foam sealant sprayed into the lungs.

23 Feb 2013

HIF-1α protein can work directly to stop new cells from forming

A protein known for turning on genes to help cells survive low-oxygen conditions also slows down the copying of new DNA strands, thus shutting down the growth of new cells, Johns Hopkins researchers report. Their discovery has wide-ranging implications, they say, given the importance of this copying - known as DNA replication - and new cell growth to many of the body's functions and in such diseases as cancer.

23 Feb 2013

Epidural analgesia may provide best form of pain relief for colorectal surgery patients

A new study in the March issue of Anesthesiology suggests epidural analgesia (EA) may be a more effective component in the perioperative care of patients undergoing elective open colorectal surgery than the proposed alternative, continuous wound infiltration of local anesthetics (CWI).

23 Feb 2013

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

EO2 Concepts has developed an innovative dressing for difficult-to-heal wounds that is as easy to apply as a Band-Aid.

23 Feb 2013

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

The U.S. Food and Drug Administration today approved Kadcyla (ado-trastuzumab emtansine), a new therapy for patients with HER2-positive, late-stage (metastatic) breast cancer.

23 Feb 2013

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA).

23 Feb 2013

Leading cancer researcher, Dr. Lewis Cantley, named a winner of the inaugural Breakthrough Prize in Life Sciences

Dr. Lewis Cantley, a leading cancer researcher credited with discovering a family of enzymes fundamental to understanding cancer, was named a winner of the inaugural Breakthrough Prize in Life Sciences, the world’s richest academic prize for medicine and biology. The prize, which carries a $3 million cash award, recognizes excellence in research aimed at curing intractable diseases and human life.

22 Feb 2013

Exposure to bullying during childhood increases risk of psychiatric disorders in adulthood

A new study shows that children who are exposed to bullying during childhood are at increased risk of psychiatric disorders in adulthood, regardless of whether they are victims or perpetrators.

22 Feb 2013

Marine-based active substances show promise against multiple myeloma

There is fierce competition in the ocean habitat. In order to survive there, marine organisms defend themselves against their rivals using an entire arsenal of chemical weapons. With the help of these substances they attack hostile cells, overcome their defence system and thus are interesting active substance candidates for cancer research.

22 Feb 2013

Physicians afraid to give thrombolytic drugs to pulmonary embolism patients for good reason

When doctors encounter a patient with a massive pulmonary embolism, they face a difficult choice: Is it wise to administer a drug that could save the patient's life, even though many people suffer life-threatening bleeding as a result? Based on new findings published in the American Journal of Medicine, Michigan State University researchers are answering that question in no uncertain terms.

22 Feb 2013

Dako, Panagene sign supply agreement for PNA oligomer component

Panagene announced it has signed a supply agreement with Dako Denmark A/S to supply PNA oligomer key component for incorporation into Dako's diagnostic or research products. Dako, an Agilent Technologies Company since June 2012, is a leading global provider of tissue-based cancer diagnostic solutions.

22 Feb 2013

Familial Hypercholesterolaemia patients often inherit small-effect changes in several genes rather than a large-effect mutation in a single gene

Research published Online First in The Lancet provides new evidence that a substantial proportion of individuals with a clinical diagnosis of Familial Hypercholesterolaemia (FH) inherit a combination of small-effect changes in several genes (polygenic) rather than a large-effect mutation in a single gene (monogenic).

22 Feb 2013

Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

Cardiovascular disease specialists at Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute affiliated with the University of South Florida announced they have enrolled their first patients into a clinical trial testing a novel gene therapy for the treatment of heart failure after ischemic injury. The therapy may promote the regeneration of heart tissue by encouraging the body to deploy more stem cells to the injury site.

22 Feb 2013

Team Danmark, Global Health Partner enter exclusive collaboration agreement

Through its subsidiary Gildhøj Privathospital, Global Health Partner is entering into an exclusive collaboration agreement with Team Danmark to provide Denmark's leading elite athletes with sports medicine and sports surgery.

22 Feb 2013

Cyclists at risk of injury due to lack of infrastructure in large urban centres

Using your bicycle to commute to work has numerous health and environmental benefits. Yet, the largest Canadian study on cycling injuries led by Ryerson University suggests cyclists are at risk of injury due to the lack of cycling infrastructure in large urban centres.

22 Feb 2013

Study finds bariatric surgery does not reduce long-term medical costs

Research disputes widely-held beliefs that the weight-loss operations cut the need for treatments and medicine after patients shed pounds.

22 Feb 2013

Medical Condition News

New, effective and less toxic therapeutic option for patients with HER2-positive breast cancer

LINX magnetic device safe and effective in treating gastroesophageal reflux disease

New data from Boehringer Ingelheim's tiotropium Respimat Phase III UniTinA-asthma programme

Clearview announces arrival of Catalys Precision Laser System in Southern CA

UAB becomes first in America to test experimental therapy for emphysema

HIF-1α protein can work directly to stop new cells from forming

Epidural analgesia may provide best form of pain relief for colorectal surgery patients

EO2 Concepts develops innovative dressing for difficult-to-heal wounds

Genentech receives FDA approval for Kadcyla to treat HER2-positive metastatic breast cancer

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Leading cancer researcher, Dr. Lewis Cantley, named a winner of the inaugural Breakthrough Prize in Life Sciences

Exposure to bullying during childhood increases risk of psychiatric disorders in adulthood

Marine-based active substances show promise against multiple myeloma

Physicians afraid to give thrombolytic drugs to pulmonary embolism patients for good reason

Dako, Panagene sign supply agreement for PNA oligomer component

Familial Hypercholesterolaemia patients often inherit small-effect changes in several genes rather than a large-effect mutation in a single gene

Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

Team Danmark, Global Health Partner enter exclusive collaboration agreement

Cyclists at risk of injury due to lack of infrastructure in large urban centres

Study finds bariatric surgery does not reduce long-term medical costs

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Latest News